Skip to content
value.today

Athenex

ATNXUnlisted company
$24 Mlast known market cap, Dec 2022 — no current value
Compare
World rank
—
no current market cap
Revenue
$144 M
annual
value.today research
Net income
$-146 M
-101.4% margin
value.today research
Employees
605
As on 2020
value.today research

Athenex in brief

Athenex is an unlisted company in the Pharmaceutical industry, based in New York, USA. In its latest reported year it had sales of $144 M and a net loss of $146 M. It employs about 605 people.

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Athenex

Biopharmaceutical company with headquarters is in New York, USA.

Athenex timeline

1 events, 2017
  1. 2017
  2. 🔔
    · approximate
    Initial public offering on Nasdaq

Events of Athenex from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

More about Athenex

Acquisitions and changes
No longer listed: ticker ATNX is not in the SEC's, the US exchanges' or FINRA's lists of traded securities (checked 14 November 2026).

Market cap history

$0 M$331 M$662 M$993 M$1.3 B202020212022

World rank over time

▼ down 21,740 places since 2020
2020-01-01: #6800#6,80020202021-01-01: #7813#7,81320212022-01-07: #20808#20,80820222022-12-25: #28540#28,5402022

Rank in USA: #1,919 (Jan 2020) · #2,208 (Jan 2021) · #4,159 (Jan 2022) · #5,197 (Dec 2022)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
—
Free cash flow yield
—
Net margin
-101.4%
Operating margin
—
Return on equity
—
Liabilities / assets
—
Revenue per employee
$238 K
Profit per employee
$-241 K

Annual results

Revenue
$144 M
Operating income
—
Net income
$-146 M

How Athenex compares in Pharmaceutical

  • Revenue$144 M · higher than 24% of 324
  • Net margin-101.4% · higher than 4% of 313

Peer comparison · Pharmaceutical

CompanyMarket capP/ENet marginRev. growth
Athenex🇺🇸$24 M—-101.4%—
Eli Lilly and Company🇺🇸$1.20 T43.4×31.9%+44.7%
Johnson & Johnson🇺🇸$652.5 B40.5×16.2%+6.0%
AbbVie Inc.🇺🇸$514.0 B49.7×15.7%+8.6%
Roche Holding AG🇨🇭$370.3 B29.1×19.0%—
Merck & Co., Inc.🇺🇸$359.8 B146.7×3.6%+1.3%
Novartis AG🇨🇭$286.8 B20.5×24.7%—
Amgen Inc.🇺🇸$249.2 B26.5×24.1%+9.9%
AstraZeneca PLC🇬🇧$242.6 B23.7×17.4%+8.6%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Dec 25, 2022 (last known)
Employees:
As on 2020
Profile updated:
Nov 14, 2026

Figures from value.today research.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Athenex? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Athenex's ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Athenex? Suggest a correction